Showing 1,528 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Fair Pricing Coalition Sign-on Letter to Gilead on Pricing of TAF

Editor's pick
TAG
10 September 2015
PrEP

Gilead applies for PrEP approval in Canada

Editor's pick
Homoculture.ca
27 August 2015
Hepatitis C treatment

Hepatitis C treatment: Back to the warehouse

Editor's pick
Clinical Liver Disease
26 August 2015
Pharmaceutical industry

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Editor's pick
Gilead press release
21 August 2015
Pharmaceutical industry

After Curing Hepatitis C, Gilead Works to Vanquish More Viruses

Editor's pick
Bloomberg
19 August 2015
Pharmaceutical industry

HIV drug ad encourages patient engagement, social media

Editor's pick
MedCity News
18 August 2015
Access to healthcare

Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

Editor's pick
Intellectual Property Watch
4 August 2015
Pharmaceutical industry

GSK flags up pipeline as HIV drugs help it beat profit forecasts

Editor's pick
Reuters
30 July 2015
Pharmaceutical industry

Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge

Editor's pick
Bloomberg
30 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal Pharmalot blog
20 July 2015
Pharmaceutical industry

TAG Pipeline Report

Editor's pick
TAG
17 July 2015
The search for an HIV prevention vaccine

One step further towards an HIV vaccine: and this one performed as expected

News
14 July 2015
The search for an HIV prevention vaccine

Bold goal of stopping HIV is motivating great science

Editor's pick
Devex
13 July 2015
Pharmaceutical industry

Success at Glaxo's HIV Unit May Mean Having to Call It Quits

Editor's pick
Bloomberg
10 July 2015
Pharmaceutical industry

Bristol-Myers to stop new antiviral drug research

Editor's pick
Reuters
26 June 2015
Access to healthcare

China rejects Gilead hepatitis C drug patent: advocacy group

Editor's pick
Reuters
19 June 2015
Pharmaceutical industry

Don’t Weaken the F.D.A.’s Drug Approval Process

Editor's pick
New York Times
12 June 2015
Access to healthcare

Trans-Pacific Partnership Transparency for the Big Pharma Wrecking Crew

Editor's pick
Health Gap
12 June 2015
Access to healthcare

U.S. Shifts Stance on Drug Pricing in Pacific Trade Pact Talks, Document Reveals

Editor's pick
New York Times
12 June 2015
Access to healthcare

The Medicines Patent Pool and Gilead Sciences Expand Licence to Allow Generic Manufacture of Medicines in South Africa

Editor's pick
Medicines Patent Pool
12 June 2015
Hepatitis C treatment

Pharma Execs Don't Know Why Anyone Is Upset by a $94,500 Miracle Cure

Editor's pick
Bloomberg
9 June 2015
Access to healthcare

Campaign for Affordable Medicine Gains Ground in South Africa

Editor's pick
Inter Press Service
3 June 2015
New & experimental HIV treatments

European Medicines Agency Validates Gilead’s Marketing Application for Fixed-Dose Combination of Emtricitabine and Tenofovir Alafenamide (F/TAF) for HIV Treatment

Editor's pick
Gilead
2 June 2015
Pharmaceutical industry

Panel: Compulsory licensing could address high-priced medicines in Europe

Editor's pick
Intellectual Property Watch
29 May 2015